European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

[1]  M. Babjuk,et al.  Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. , 2017, European urology.

[2]  R. Autorino,et al.  Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta‐analysis , 2017, BJU international.

[3]  Scott C. Johnson,et al.  Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical Approach. , 2017, Journal of endourology.

[4]  M. Menon,et al.  Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma. , 2017, European urology.

[5]  K. Bensalah,et al.  Postoperative Nomogram for Relapse‐Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma , 2017, The Journal of urology.

[6]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[7]  N. Lawrentschuk,et al.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review , 2017, World Journal of Urology.

[8]  M. Babjuk,et al.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[9]  V. Margulis,et al.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma , 2017, World Journal of Urology.

[10]  K. Bensalah,et al.  Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy , 2017, World Journal of Urology.

[11]  V. Margulis,et al.  Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction , 2017, The Journal of urology.

[12]  S. Barni,et al.  Prognostic Factors of Overall Survival in Upper Urinary Tract Carcinoma: A Systematic Review and Meta-analysis. , 2017, Urology.

[13]  K. Bensalah,et al.  HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[14]  R. Bourgon,et al.  Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial , 2017, The Lancet.

[15]  Steven L. Chang,et al.  EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY AFTER RADICAL NEPHROURETERECTOMY FOR LOCALLY ADVANCED AND/OR POSITIVE REGIONAL LYMPH NODE UPPER TRACT UROTHELIAL CARCINOMA: MP71‐09 , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Ying-Hsu Chang,et al.  Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma , 2016, Scientific Reports.

[17]  M. Babjuk,et al.  Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. , 2016, European urology.

[18]  T G van Leeuwen,et al.  Optical Coherence Tomography as a Tool for In Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study of Diagnostic Accuracy. , 2016, The Journal of urology.

[19]  S. Bhayani,et al.  Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data. , 2016, Urology.

[20]  F. Montorsi,et al.  Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings , 2016, World Journal of Urology.

[21]  V. Bhatt,et al.  Effect of Adjuvant Radiotherapy on Survival in Patients with Locoregional Urothelial Malignancies of the Upper Urinary Tract. , 2016, Anticancer research.

[22]  H. S. Kim,et al.  Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis , 2016, Oncotarget.

[23]  K. Bensalah,et al.  Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study , 2016, World Journal of Urology.

[24]  G. Nabi,et al.  Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour. , 2016, Photodiagnosis and photodynamic therapy.

[25]  A. Alcaraz,et al.  Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy , 2016, Scandinavian journal of urology.

[26]  L. S. Singh,et al.  Retrospective Evaluation of Risk Factors and Immunohistochemical Findings for Pre-Neoplastic and Neoplastic lesions of Upper Urinary Tract in Patients with Chronic Nephrolithiasis. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[27]  A. Hemal,et al.  Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma. , 2015, The Journal of urology.

[28]  J. Coleman,et al.  Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates. , 2015, The Journal of urology.

[29]  O. Cussenot,et al.  A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. , 2015, European urology.

[30]  F. Montorsi,et al.  Conditional survival after radical nephroureterectomy for upper tract carcinoma. , 2015, European urology.

[31]  H. Matsuyama,et al.  Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma , 2015, International Journal of Clinical Oncology.

[32]  P. Colin,et al.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours , 2015, Nature Reviews Urology.

[33]  A. Ouzzane,et al.  Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy , 2015, World Journal of Urology.

[34]  D. D. de Bruin,et al.  Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. , 2015, Journal of endourology.

[35]  S. Shariat,et al.  Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[36]  K. Bensalah,et al.  Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis , 2014, BJU international.

[37]  K. Moon,et al.  Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems. , 2014, The Journal of urology.

[38]  T. Kwon,et al.  Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma , 2014, Journal of surgical oncology.

[39]  Steven L. Chang,et al.  A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. , 2014, European urology.

[40]  P. Colin,et al.  A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs. , 2014, European urology.

[41]  Y. Lotan,et al.  Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy , 2014, BJU international.

[42]  V. Margulis,et al.  Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma , 2014, Cancer.

[43]  Kazuhiko Yoshida,et al.  Template‐based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study , 2014 .

[44]  K. Pummer,et al.  Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma , 2014, British Journal of Cancer.

[45]  A. Masson-Lecomte,et al.  Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma , 2014, World Journal of Urology.

[46]  F. Montorsi,et al.  Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. , 2014, European urology.

[47]  Q. Ding,et al.  Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma , 2014, Scientific Reports.

[48]  R. Leveillee,et al.  Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. , 2013, Urologic oncology.

[49]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.

[50]  P. Black,et al.  Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. , 2013, Urologic oncology.

[51]  K. Moon,et al.  External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2013, British Journal of Cancer.

[52]  Xuesong Li,et al.  Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis , 2013, Urologia Internationalis.

[53]  Y. Lotan,et al.  Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. , 2013, Urologic oncology.

[54]  M. Babjuk,et al.  Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. , 2013, European urology.

[55]  Richard Sylvester,et al.  European guidelines on upper tract urothelial carcinomas: 2013 update. , 2013, European urology.

[56]  K. Bensalah,et al.  Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. , 2013, The Journal of urology.

[57]  Takuhiro Yamaguchi,et al.  Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  David A. Green,et al.  Urothelial carcinoma of the bladder and the upper tract: disparate twins. , 2013, The Journal of urology.

[59]  B. Guillonneau,et al.  Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy. , 2013, The Journal of urology.

[60]  M. Cosentino,et al.  Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma , 2013, World Journal of Urology.

[61]  A. Ouzzane,et al.  The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi‐institutional collaborative study , 2012, BJU international.

[62]  F. Montorsi,et al.  Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: Comparison over the three decades , 2012, International journal of urology : official journal of the Japanese Urological Association.

[63]  F. Saint,et al.  A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool , 2012, BJU international.

[64]  S. Phipps,et al.  Long‐term endoscopic management of upper tract urothelial carcinoma: 20‐year single‐centre experience , 2012, BJU international.

[65]  F. Saint,et al.  Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study , 2012, BJU international.

[66]  S. Phipps,et al.  Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review , 2012, BJU international.

[67]  F. Montorsi,et al.  International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis , 2012, BJU international.

[68]  J. McKiernan,et al.  Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion , 2012, BJU international.

[69]  S. Shariat,et al.  Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. , 2012, Urologic oncology.

[70]  David A. Green,et al.  Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. , 2012, The Journal of urology.

[71]  F. Saint,et al.  Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival , 2012, Annals of Surgical Oncology.

[72]  V. Margulis,et al.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. , 2012, European urology.

[73]  S. Shariat,et al.  Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy , 2012, BJU international.

[74]  Ruifa Han,et al.  Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. , 2012, European urology.

[75]  K. Bensalah,et al.  Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. , 2012, Urologic oncology.

[76]  V. Margulis,et al.  Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. , 2012, European urology.

[77]  W. Roberts,et al.  Long-term outcomes of immediate versus delayed nephroureterectomy for upper tract urothelial carcinoma. , 2012, Journal of endourology.

[78]  Y. Lotan,et al.  High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. , 2012, Journal of endourology.

[79]  S. Shariat,et al.  Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study , 2012, BJU international.

[80]  K. Bensalah,et al.  Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. , 2012, European urology.

[81]  N. Cowan.  CT urography for hematuria , 2012, Nature Reviews Urology.

[82]  B. Jelaković,et al.  Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. , 2012, Kidney international.

[83]  O. Cussenot,et al.  Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. , 2012, Urologic oncology.

[84]  K. Bensalah,et al.  Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma. , 2012, The Journal of urology.

[85]  S. Crouzet,et al.  Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram , 2012, British Journal of Cancer.

[86]  K. Bensalah,et al.  The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. , 2012, European urology.

[87]  G. Cancel-Tassin,et al.  Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis. , 2012, The Journal of urology.

[88]  J. Coleman,et al.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma , 2012, BJU international.

[89]  M. Dimopoulos,et al.  Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) , 2011, Cancer.

[90]  F. Saint,et al.  Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. , 2011, European urology.

[91]  T. Kessler,et al.  Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? , 2011, European urology.

[92]  F. Montorsi,et al.  Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? , 2011, Urologic oncology.

[93]  T. O'brien,et al.  Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). , 2011, European urology.

[94]  Y. Lotan,et al.  Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. , 2011, European urology.

[95]  K. Bensalah,et al.  Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study , 2011, BJU international.

[96]  Yair Lotan,et al.  Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma , 2011, BJU international.

[97]  A. Ouzzane,et al.  Small cell carcinoma of the upper urinary tract (UUT-SCC): report of a rare entity and systematic review of the literature. , 2011, Cancer treatment reviews.

[98]  S. Shariat,et al.  Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort , 2011, BJU international.

[99]  S. Shariat,et al.  Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma , 2011, World Journal of Urology.

[100]  W. Lowrance,et al.  Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. , 2011, The Journal of urology.

[101]  O. Cussenot,et al.  Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? , 2011, BJU international.

[102]  J. Jones,et al.  Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. , 2011, Urology.

[103]  K. Bensalah,et al.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas , 2011, World Journal of Urology.

[104]  M. Jinzaki,et al.  Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. , 2011, The Journal of urology.

[105]  Y. Pu,et al.  Arsenics and Urothelial Carcinoma , 2011 .

[106]  S. Shariat,et al.  Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy , 2011, World Journal of Urology.

[107]  A. Şimşir,et al.  Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status , 2011, International Urology and Nephrology.

[108]  S. Shariat,et al.  Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients , 2011, World Journal of Urology.

[109]  J. Coleman,et al.  Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? , 2010, European urology.

[110]  S. Shariat,et al.  Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. , 2010, The Journal of urology.

[111]  M. Stifelman,et al.  Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.

[112]  F. Ito,et al.  Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival , 2010, International journal of urology : official journal of the Japanese Urological Association.

[113]  Y. Matsuno,et al.  Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. , 2010, The Journal of urology.

[114]  M. Bibbo,et al.  Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance. , 2010, The Journal of urology.

[115]  P. Acher,et al.  TOWARDS A RATIONAL STRATEGY FOR THE SURVEILLANCE OF PATIENTS WITH LYNCH SYNDROME (HEREDITARY NON‐POLYPOSIS COLON CANCER) FOR UPPER TRACT TRANSITIONAL CELL CARCINOMA , 2010, BJU international.

[116]  F. Montorsi,et al.  Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. , 2010, The Journal of urology.

[117]  R. Millikan,et al.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high‐risk upper tract transitional cell carcinoma , 2010, Cancer.

[118]  Y. Lotan,et al.  Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. , 2010, The Journal of urology.

[119]  B. Lane,et al.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy , 2010, Cancer.

[120]  Wen-Jeng Wu,et al.  Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. , 2010, European urology.

[121]  F. Montorsi,et al.  Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. , 2010, European urology.

[122]  S. Shariat,et al.  Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. , 2010, European urology.

[123]  F. Montorsi,et al.  Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. , 2010, The Journal of urology.

[124]  K. Bensalah,et al.  Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. , 2010, European urology.

[125]  M. Babjuk,et al.  Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. , 2010, European urology.

[126]  B. Leibovich,et al.  Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. , 2010, The Journal of urology.

[127]  M. Grasso,et al.  Ureteroscopic laser treatment of upper urinary tract neoplasms , 2010, World Journal of Urology.

[128]  N. Rofsky,et al.  MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy. , 2010, Clinical radiology.

[129]  K. Bensalah,et al.  A delay in radical nephroureterectomy can lead to upstaging , 2010, BJU international.

[130]  F. Montorsi,et al.  A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. , 2010, Urology.

[131]  F. Montorsi,et al.  Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. , 2009, European journal of cancer.

[132]  K. Bensalah,et al.  Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy , 2009, BJU international.

[133]  A. Ouzzane,et al.  Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract , 2009, BJU international.

[134]  F. Montorsi,et al.  Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. , 2009, The Journal of urology.

[135]  M. Gallucci,et al.  Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. , 2009, European urology.

[136]  L. Lacombe,et al.  Carcinoma of the upper urinary tract , 2009, Cancer.

[137]  A. Finelli,et al.  Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. , 2009, Urology.

[138]  Y. Lotan,et al.  Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.

[139]  K. Bensalah,et al.  Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients , 2009, BJU international.

[140]  K. Bensalah,et al.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[141]  C. Chuang,et al.  Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. , 2009, The Journal of urology.

[142]  H. Wallerand,et al.  Oncological risk of laparoscopic surgery in urothelial carcinomas , 2009, World Journal of Urology.

[143]  O. Cussenot,et al.  Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. , 2008, European urology.

[144]  M. Grasso,et al.  Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma? , 2008, Journal of endourology.

[145]  K. Bensalah,et al.  Challenges of cancer biomarker profiling. , 2007, European urology.

[146]  B. Jelaković,et al.  Aristolochic acid and the etiology of endemic (Balkan) nephropathy , 2007, Proceedings of the National Academy of Sciences.

[147]  N. Cowan,et al.  Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour , 2007, BJU international.

[148]  O. Cussenot,et al.  Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. , 2007, European urology.

[149]  S. Suster,et al.  High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants , 2006, Modern Pathology.

[150]  F. Hamdy,et al.  Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. , 2006, Urology.

[151]  R Y Ball,et al.  Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .

[152]  D. Lifshitz,et al.  Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation. , 2005, The Journal of urology.

[153]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[154]  M. Mazumdar,et al.  Urothelial Carcinoma of the Renal Pelvis: A Clinicopathologic Study of 130 Cases , 2004, The American journal of surgical pathology.

[155]  A. Zietman,et al.  Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. , 2004, The Journal of urology.

[156]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[157]  S. Bhayani,et al.  Trocar site recurrence after laparoscopic nephroureterectomy. , 2003, The Journal of urology.

[158]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[159]  I. Fernandez,et al.  Pyelocaliceal urothelial carcinoma associated with pelvis lithiasis , 1998 .

[160]  H. Herr,et al.  Extravesical tumor relapse in patients with superficial bladder tumors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[161]  D. Knapp,et al.  Tumors of the Urinary System , 2019, Withrow and MacEwen's Small Animal Clinical Oncology.

[162]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[163]  T. Clozel,et al.  External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study. , 2017, Urologic oncology.

[164]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. , 2015, European urology.

[165]  T. Clozel,et al.  Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. , 2014, European urology.

[166]  V. Margulis,et al.  Upper tract urothelial carcinoma: impact of time to surgery. , 2012, Urologic oncology.

[167]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[168]  F. Saint,et al.  Assessment of Oncologic Control Obtained After Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas (UUT-UCs): Results from a Large French Multicenter Collaborative Study , 2011, Annals of Surgical Oncology.

[169]  Kuo-Hsin Chen,et al.  Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade, et al. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 2010;58:645-651. , 2011, European Urology.

[170]  F. Montorsi,et al.  A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. , 2010, Urology.

[171]  K. Bensalah,et al.  Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. , 2009, Urology.

[172]  O. Cussenot,et al.  Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma , 2009, World Journal of Urology.

[173]  T. Uchida,et al.  Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. , 2002, Urology.

[174]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[175]  K. Nakagawa,et al.  The Over Time Conditional Survival of Intravesical Recurrence in Upper Tract Urothelial Carcinoma , 2022 .